As we adjust our print schedule, launch a new website and rely on the U.S. Postal Service for delivery, please know these changes were not made lightly. They were made with our readers in mind — and ...

The U.S. Forest Service is introducing N95 masks and new decontamination protocols to protect wildland firefighters.

AdJane, a clinical-stage vaccine platform company developing intranasal and intramuscular vaccines based on native Outer Membrane Vesicles (nOMVs), today announces the publication of first-in-human ...

Flu season is no longer just flu season. Since 2022, the health care community has faced what's known as a "tripledemic" of ...

Although wildland firefighters are at high risk for smoke-related health issues, the U.S. Forest Service has for decades not ...

MELBOURNE, Australia, June 15, 2026 (GLOBE NEWSWIRE) -- ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated with ...

In 1985, Québec established a no-fault Vaccine Injury Compensation Program, that is, forgoing the need to determine liability or fault on the part of stakeholders. The program was renewed under the ...

Winter respiratory illnesses are often thought of as a nuisance that can keep you in bed and away from work or school for a few days. But if you’re susceptible to severe infection, they can land you ...

Respiratory syncytial virus (RSV) is a familiar seasonal illness, but the tools to prevent it are new. Canada has recently approved vaccines for older adults and pregnant people, along with a ...

Objectives To compare the impact of respirator extended use and reuse strategies with regard to cost and sustainability during the COVID-19 pandemic. Design Cost analysis. Setting USA. Participants ...

Background Following a relative absence in winter 2020, a large resurgence of respiratory syncytial virus (RSV) detections occurred during the 2020/2021 summer in Western Australia. This seasonal ...

The need for more effective protection against influenza continues to grow, as the virus consistently causes significant illness and mortality worldwide New human clinical data from Leyden Labs show ...